We are doing science for policy
The Joint Research Centre (JRC) is the European Commission's science and knowledge service which employs scientists to carry out research in order to provide independent scientific advice and support to EU policy.
Scientists from the JRC and US Environmental Protection Agency examined how and to what extent mathematical models of biological organisms are used in toxicology, and identified a number of challenges that need to be overcome for wider use and regulatory acceptance of these non-animal approaches.
The JRC has published an interactive European map with information on breast cancer screening, diagnosis, treatment and follow-up care for 35 countries. The map provides a Europe-wide snapshot to help the EU and Member States secure equal access to high quality care across the continent.
The European Commission’s Joint Research Centre (JRC) is developing the EU Platform on Rare Diseases Registration. An important component of the Platform is the Central Registry of the Network for the Surveillance of Cerebral Palsy in Europe (SCPE), which was recently transferred to the JRC.
The Annual Plenary Meeting of the SCPE was organised by the JRC from 16th to 18th October 2017. A significant part of the programme was devoted to the discussion of indicators for measuring public health impact of cerebral palsy.
EU-NETVAL is a large network of highly qualified test facilities across Europe, coordinated by the Joint Research Centre to support the in vitro method validation process.
JRC scientists have shown that human induced pluripotent stem cell-derived neurons are suitable non-animal models for testing neurotoxicity during brain development. The study revealed that long term exposure to the pesticide rotenone induces oxidative stress and can trigger neuronal cell death.